Wockhardt EU Operations

Wockhardt is a global pharmaceutical and biotechnology company with a significant operational footprint in the European Union, primarily through its UK-based subsidiaries. The company specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical formulations, including generics, branded medicines, and complex biologics such as insulin. Wockhardt's EU operations are centered around high-tech manufacturing facilities in Wrexham and Huddersfield, which provide sterile injectables and fill-finish services for global partners, including a notable role in vaccine production. The company maintains a robust research and development focus on novel anti-infectives (NCEs) designed to combat multi-drug resistant "superbugs." As a major supplier to the National Health Service (NHS) and other European healthcare systems, Wockhardt is a key player in the regional pharmaceutical supply chain.